Genteract

Curated by Signal

Systems biology platform for precision medicine

Overview

Genteract is commercializing a patented systems biology platform that uses human genomic data to detect gene-environment interactions using continuous variables. The company claims that their platform can predict possible side effects a patient will have by taking a particular drug, repurpose existing drugs, and match drugs to patients.

Key facts

Founded: 2016
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Epitomie Fitness
Online store offering fitness equipment and accessories
Health TechnologyMiami, United States
Dickson
Provider of environmental monitoring solutions for healthcare providers
Health TechnologyAddison, United States
Evassupplements
Online platform offering health and fitness supplements
Health TechnologyNew York City, United States

About Genteract

What does Genteract do?

Genteract is commercializing a patented systems biology platform that uses human genomic data to detect gene-environment interactions using continuous variables.

Where is Genteract headquartered?

Genteract is headquartered in San Francisco, United States.

When was Genteract founded?

Genteract was founded in 2016.

Which sector is Genteract in?

Genteract operates in Health Technology.

Who are Genteract's competitors?

Companies similar to Genteract include Epitomie Fitness, Dickson, and Evassupplements.